Our US Ophthalmology team is committed to transforming the lives of patients living with diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) with a portfolio of two products in the pipeline.
Base: $142,400.00 - $224,100.00; Bonus/Equity: Eligible for annual bonus and long-term incentive; Benefits: Comprehensive medical, dental, vision, retirement, paid holidays and sick days
Must-have
Nice-to-have
U.S. and Puerto Rico residents only